Skip to content

ROTABLATOR ROTATIONAL ANGIOPLASTY SYSTEM ROTABLATOR SYSTEM'S GUIDE WIRE LINE - Hti Floppy

by Heart Technology Mfg., Inc.

510(k) K954604

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK954604 Date18 Jan 1996ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MCW
Device Class
Class II
Regulation
21 CFR Part 870.4875
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Rotablator Rotational Atherectomy System is a catheter-based device designed for peripheral atherectomy, using a high-speed rotating burr to mechanically ablate calcified or hardened plaque within blood vessels. It falls under the category of peripheral atherectomy catheters and is intended for use in percutaneous interventions to restore vessel lumen patency in calcified lesions.

The system is supplied as a reusable medical device, incorporating a guide wire line (HTI Floppy) for navigation and procedural support. It is regulated under FDA 510(k) clearance (K954604) and classified as a Class II device (regulation number 870.4875). The device requires sterile handling and is intended for use in controlled clinical settings, with specific burr sizes and guide catheter compatibility as outlined in procedural guidelines.

Other devices from Heart Technology, Inc.

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is the Rotablator Rotational Atherectomy System designed for use in coronary arteries, or is it specifically for peripheral vessels?

    The Rotablator Rotational Atherectomy System is designed specifically for peripheral atherectomy, meaning it is intended for use in peripheral blood vessels, not coronary arteries. It uses a high-speed rotating burr to mechanically ablate calcified plaque in peripheral arteries to restore vessel lumen patency during percutaneous interventions.

  • How is the Rotablator System’s Guide Wire Line (HTI Floppy) supplied, and is it reusable or single-use?

    The Rotablator System’s Guide Wire Line (HTI Floppy) is supplied as a reusable component of the overall Rotablator Rotational Atherectomy System. This means it is intended to be used multiple times after proper cleaning and sterilization, rather than being discarded after a single procedure.

  • What types of sterility precautions should be taken when handling the Rotablator System?

    The Rotablator System requires sterile handling, as indicated in its design and regulatory classification. While the reusable components like the guide wire line are not sterile out-of-the-box, they must be cleaned and sterilized before reuse. The burrs and other disposable components must be handled in a sterile manner to maintain clinical standards during procedures.

  • What is the regulatory pathway for the Rotablator Rotational Atherectomy System, and what does this mean for clinicians?

    The Rotablator System was cleared through the FDA’s 510(k) pathway, specifically under the traditional review process with a decision code of ‘Substantially Equivalent’ (SESE). This means it was determined to be substantially equivalent to a legally marketed predicate device, ensuring it meets FDA safety and effectiveness standards for peripheral atherectomy catheters. Clinicians can rely on this clearance as part of the device’s regulatory approval.